Incyte (NASDAQ:INCY) Price Target Raised to $77.00
Incyte (NASDAQ:INCY – Free Report) had its price objective hoisted by Stifel Nicolaus from $75.00 to $77.00 in a report released on Monday morning,Benzinga reports. Stifel Nicolaus currently has a hold rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently weighed in on INCY. Oppenheimer raised their target price on […]
Incyte (NASDAQ:INCY – Free Report) had its price objective hoisted by Stifel Nicolaus from $75.00 to $77.00 in a report released on Monday morning,Benzinga reports. Stifel Nicolaus currently has a hold rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently weighed in on INCY. Oppenheimer raised their target price on […]
